Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

KalVista Pharmaceuticals, Inc. (KALV)

Sweeny Nicole — Chief Commercial Officer
Feb 23, 2026
Sale
Shares
3,975
Price
$15.57
Total Value
$61.88K
Shares Held After
47,003
% of Holdings
7.8%
Feb 23, 2026
Sale
Shares
10,034
Price
$15.57
Total Value
$156.20K
Shares Held After
442,883
% of Holdings
2.2%
Feb 23, 2026
Sale
Shares
165,000
Price
$10.25
Total Value
$1.69M
Shares Held After
2,925,821
% of Holdings
5.3%

KalVista Pharmaceuticals, Inc. (KALV)

Audhya Paul K. — CHIEF MEDICAL OFFICER
Feb 23, 2026
Sale
Shares
5,354
Price
$15.57
Total Value
$83.34K
Shares Held After
138,983
% of Holdings
3.7%

KalVista Pharmaceuticals, Inc. (KALV)

Yea Christopher — CHIEF DEVELOPMENT OFFICER
Feb 23, 2026
Sale
Shares
4,347
Price
$15.57
Total Value
$67.67K
Shares Held After
226,701
% of Holdings
1.9%

Vir Biotechnology, Inc. (VIR)

Sabatini Brent — SVP, Chief Accounting Officer
Feb 23, 2026
Sale
Shares
1,829
Price
$7.45
Total Value
$13.63K
Shares Held After
71,043
% of Holdings
2.5%
Feb 23, 2026
Sale
Shares
19,039
Price
$7.45
Total Value
$141.89K
Shares Held After
1,035,466
% of Holdings
1.8%

KalVista Pharmaceuticals, Inc. (KALV)

Piekos Brian — Chief Financial Officer
Feb 23, 2026
Sale
Shares
1,767
Price
$15.57
Total Value
$27.51K
Shares Held After
13,762
% of Holdings
11.4%

Vir Biotechnology, Inc. (VIR)

de Verneuil Vanina — EVP, General Counsel, Corp Sec
Feb 23, 2026
Sale
Shares
4,445
Price
$7.45
Total Value
$33.13K
Shares Held After
129,799
% of Holdings
3.3%

Vir Biotechnology, Inc. (VIR)

O'Byrne Jason — EVP & Chief Financial Officer
Feb 23, 2026
Sale
Shares
2,089
Price
$7.45
Total Value
$15.57K
Shares Held After
164,249
% of Holdings
1.3%

Vir Biotechnology, Inc. (VIR)

Eisner Mark — EVP and Chief Medical Officer
Feb 23, 2026
Sale
Shares
2,089
Price
$7.45
Total Value
$15.57K
Shares Held After
157,529
% of Holdings
1.3%
Feb 23, 2026
Sale
Shares
476
Price
$19.06
Total Value
$9.07K
Shares Held After
325,795
% of Holdings
0.1%
Feb 23, 2026
Sale
Shares
10,788
Price
$18.39
Total Value
$198.39K
Shares Held After
326,271
% of Holdings
3.2%

TACTILE SYSTEMS TECHNOLOGY INC (TCMD)

Birkemeyer Elaine M. — CHIEF FINANCIAL OFFICER
Feb 23, 2026
Sale
Shares
196
Price
$28.69
Total Value
$5.62K
Shares Held After
142,520
% of Holdings
0.1%

TACTILE SYSTEMS TECHNOLOGY INC (TCMD)

Birkemeyer Elaine M. — CHIEF FINANCIAL OFFICER
Feb 23, 2026
Sale
Shares
5,322
Price
$28.28
Total Value
$150.52K
Shares Held After
142,716
% of Holdings
3.6%
Feb 23, 2026
Sale
Shares
1,637
Price
$147.62
Total Value
$241.65K
Shares Held After
20,299
% of Holdings
7.5%
Feb 23, 2026
Sale
Shares
572
Price
$146.95
Total Value
$84.06K
Shares Held After
21,936
% of Holdings
2.5%
Feb 23, 2026
Sale
Shares
1,725
Price
$145.32
Total Value
$250.67K
Shares Held After
22,508
% of Holdings
7.1%
Feb 23, 2026
Sale
Shares
1,378
Price
$143.40
Total Value
$197.61K
Shares Held After
24,233
% of Holdings
5.4%

TACTILE SYSTEMS TECHNOLOGY INC (TCMD)

Burns Kristie — Sr. VP Mktg & Clinical Affairs
Feb 23, 2026
Sale
Shares
160
Price
$28.69
Total Value
$4.59K
Shares Held After
88,827
% of Holdings
0.2%

TACTILE SYSTEMS TECHNOLOGY INC (TCMD)

Burns Kristie — Sr. VP Mktg & Clinical Affairs
Feb 23, 2026
Sale
Shares
4,279
Price
$28.28
Total Value
$121.02K
Shares Held After
88,987
% of Holdings
4.6%
Feb 23, 2026
Sale
Shares
537
Price
$28.69
Total Value
$15.41K
Shares Held After
254,878
% of Holdings
0.2%
Feb 23, 2026
Sale
Shares
14,703
Price
$28.28
Total Value
$415.84K
Shares Held After
255,415
% of Holdings
5.4%
Feb 23, 2026
Sale
Shares
162,291
Price
$0.60
Total Value
$96.92K
Shares Held After
2,211,757
% of Holdings
6.8%
Feb 23, 2026
Sale
Shares
143,709
Price
$0.60
Total Value
$85.82K
Shares Held After
1,958,509
% of Holdings
6.8%

Hinge Health, Inc. (HNGE)

Budge James — Chief Financial Officer
Feb 23, 2026
Sale
Shares
900
Price
$40.43
Total Value
$36.39K
Shares Held After
420,132
% of Holdings
0.2%

Hinge Health, Inc. (HNGE)

Budge James — Chief Financial Officer
Feb 23, 2026
Sale
Shares
6,297
Price
$39.90
Total Value
$251.27K
Shares Held After
421,032
% of Holdings
1.5%

Hinge Health, Inc. (HNGE)

Budge James — Chief Financial Officer
Feb 23, 2026
Sale
Shares
7,566
Price
$38.74
Total Value
$293.08K
Shares Held After
427,329
% of Holdings
1.7%

Monte Rosa Therapeutics, Inc. (GLUE)

Janku Filip — Chief Medical Officer
Feb 23, 2026
Sale
Shares
9,189
Price
$19.50
Total Value
$179.16K
Shares Held After
65,837
% of Holdings
12.2%

Hinge Health, Inc. (HNGE)

Pursley James — President
Feb 23, 2026
Sale
Shares
308
Price
$40.46
Total Value
$12.46K
Shares Held After
752,231
% of Holdings
0.0%

Hinge Health, Inc. (HNGE)

Pursley James — President
Feb 23, 2026
Sale
Shares
6,818
Price
$39.95
Total Value
$272.36K
Shares Held After
752,539
% of Holdings
0.9%

Hinge Health, Inc. (HNGE)

Pursley James — President
Feb 23, 2026
Sale
Shares
7,874
Price
$38.76
Total Value
$305.16K
Shares Held After
759,357
% of Holdings
1.0%

Addus HomeCare Corp (ADUS)

RAINES MONICA — EVP, CCO and Quality Officer
Feb 23, 2026
Sale
Shares
446
Price
$114.91
Total Value
$51.25K
Shares Held After
14,457
% of Holdings
3.0%
Feb 23, 2026
Sale
Shares
30,000
Price
$8.03
Total Value
$240.90K
Shares Held After
93,469
% of Holdings
24.3%

Addus HomeCare Corp (ADUS)

BLESSING CLIFF DONALD — EVP, Chief Development Officer
Feb 23, 2026
Sale
Shares
371
Price
$114.91
Total Value
$42.63K
Shares Held After
12,888
% of Holdings
2.8%

Addus HomeCare Corp (ADUS)

TUCKER DAVID W. — EVP, Chief Strategy Officer
Feb 23, 2026
Sale
Shares
658
Price
$114.91
Total Value
$75.61K
Shares Held After
11,506
% of Holdings
5.4%
Feb 23, 2026
Purchase
Shares
15,000
Price
$17.81
Total Value
$267.15K
Shares Held After
20,255
% of Holdings
74.1%

Addus HomeCare Corp (ADUS)

Stevenson Roberton James — EVP, Chief HR Officer
Feb 23, 2026
Sale
Shares
561
Price
$114.91
Total Value
$64.46K
Shares Held After
14,881
% of Holdings
3.6%

UNITED THERAPEUTICS Corp (UTHR)

BENKOWITZ MICHAEL — PRESIDENT AND COO
Feb 23, 2026
Sale
Shares
5,065
Price
$472.13
Total Value
$2.39M
Shares Held After
0
% of Holdings
100.0%

UNITED THERAPEUTICS Corp (UTHR)

BENKOWITZ MICHAEL — PRESIDENT AND COO
Feb 23, 2026
Sale
Shares
9,375
Price
$472.13
Total Value
$4.43M
Shares Held After
0
% of Holdings
100.0%

Addus HomeCare Corp (ADUS)

WATTENBARGER MICHAEL D. — EVP, Chief Information Officer
Feb 23, 2026
Sale
Shares
577
Price
$114.91
Total Value
$66.30K
Shares Held After
10,336
% of Holdings
5.3%

Addus HomeCare Corp (ADUS)

Anderson Darby — EVP, Chief Govt Rel Officer
Feb 23, 2026
Sale
Shares
666
Price
$114.91
Total Value
$76.53K
Shares Held After
47,375
% of Holdings
1.4%
Feb 23, 2026
Sale
Shares
4,535
Price
$114.91
Total Value
$521.12K
Shares Held After
190,502
% of Holdings
2.3%

Addus HomeCare Corp (ADUS)

POFF BRIAN — EVP, Chief Financial Officer
Feb 23, 2026
Sale
Shares
1,858
Price
$114.91
Total Value
$213.50K
Shares Held After
66,553
% of Holdings
2.7%

Addus HomeCare Corp (ADUS)

GAFFNEY SEAN — EVP, Chief Legal Officer
Feb 23, 2026
Sale
Shares
737
Price
$114.91
Total Value
$84.69K
Shares Held After
21,339
% of Holdings
3.3%

Roivant Sciences Ltd. (ROIV)

Torti Frank — President and Vant Chair
Feb 23, 2026
Sale
Shares
587,390
Price
$27.51
Total Value
$16.16M
Shares Held After
13,736,547
% of Holdings
4.1%

BIODESIX INC (BDSX)

O'Kane Kieran — Chief Commercial Officer
Feb 23, 2026
Sale
Shares
535
Price
$12.78
Total Value
$6.83K
Shares Held After
9,819
% of Holdings
5.2%

BIODESIX INC (BDSX)

Vazquez Chris — Chief Accounting Officer
Feb 23, 2026
Sale
Shares
211
Price
$12.78
Total Value
$2.70K
Shares Held After
1,586
% of Holdings
11.7%

BIODESIX INC (BDSX)

Hutton Scott — Director
Feb 23, 2026
Sale
Shares
1,490
Price
$12.78
Total Value
$19.04K
Shares Held After
48,767
% of Holdings
3.0%

BIODESIX INC (BDSX)

Cowie Robin Harper — CFO, Sec'y & Treasurer
Feb 23, 2026
Sale
Shares
535
Price
$12.78
Total Value
$6.83K
Shares Held After
16,231
% of Holdings
3.2%
Version: v26.3.33